| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Erlotinib Impurity 26 |
厄洛替尼雜質(zhì)26 |
3943-89-3 |
詳細(xì)
|
| Ezetimibe Impurity M |
依折麥布雜質(zhì)M |
|
詳細(xì)
|
| Erlotinib-d6 HCl |
厄洛替尼雜質(zhì) |
1189953-78-3 |
詳細(xì)
|
| Folic acid EP impurity F |
葉酸EP雜質(zhì)F |
1391194-56-1 |
詳細(xì)
|
| Ivabradine IMpurity 2 |
伊伐布雷定雜質(zhì)2 |
|
詳細(xì)
|
| Febuxostat Impurity 26;3-cyano-4-isobutoxybenzoic acid |
非布索坦雜質(zhì)26 |
1886961-39-2 |
詳細(xì)
|
| Febuxostat Impurity 27;3-cyano-4-isobutoxybenzamide |
非布索坦雜質(zhì)27 |
|
詳細(xì)
|
| Folic Acid EP Impurity B(Sulfate) |
葉酸EP雜質(zhì)B硫酸鹽 |
35011-47-3 |
詳細(xì)
|
| Valsartan Methyl Ester |
非布索坦雜質(zhì)48 |
2375033-35-3 |
詳細(xì)
|
| Febuxostat Impurity 58;2-(3-carbamoyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)58 |
2227293-68-5 |
詳細(xì)
|
| Fudosteine |
福多司坦 |
13189-98-5 |
詳細(xì)
|
| Tofacitinib Impurity FD+DX |
福多司坦雜質(zhì) |
209665-22-5 |
詳細(xì)
|
| Febuxostat Impurity 46 |
非布司他雜質(zhì)46 |
528607-60-5 |
詳細(xì)
|
| Gefitinib iMpurity B |
吉非替尼雜質(zhì)B |
|
詳細(xì)
|
| Erlotinib O-Desmethyl Metabolite Isomer (M13) HCl |
厄洛替尼雜質(zhì) |
183365-34-6 |
詳細(xì)
|
| erythro-Hydroxy Bupropion HCl |
安非他酮雜質(zhì) |
80478-43-9 |
詳細(xì)
|
| Folic Acid Impurity 4 |
葉酸雜質(zhì)4 |
921-03-9 |
詳細(xì)
|
| Ibuprofen Impurity H |
布洛芬EP雜質(zhì)H |
|
詳細(xì)
|
| Febuxostat Impurity 42 |
非布司他雜質(zhì)42 |
100118-38-5 |
詳細(xì)
|
| Febuxostat Impurity 45 |
非布司他雜質(zhì)45 |
1229019-33-3 |
詳細(xì)
|
| Erlotinib iMpurity 41 |
厄洛替尼雜質(zhì)41 |
14235-81-5 |
詳細(xì)
|
| Erlotinib Impurity 35 |
厄洛替尼雜質(zhì)35 |
1839513-98-2 |
詳細(xì)
|
| Febuxostat related Compound 2;2-nitrobenzene-1,3,5-tricarbonitrile |
非布索坦起始物料2 |
|
詳細(xì)
|
| Ivabradine related compound 13;(E)-ethyl N-((3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)formimidate |
伊伐布雷定相關(guān)化合物13 |
|
詳細(xì)
|
| Erlotinib Impurity 30 |
厄洛替尼雜質(zhì)30 |
183322-16-9 |
詳細(xì)
|
| Non-masartan |
非馬沙坦雜質(zhì)F |
247257-48-3 |
詳細(xì)
|
| Folic Acid Impurity 3 |
葉酸雜質(zhì)3 |
47707-78-8 |
詳細(xì)
|
| Erlotinib Impurity 45 |
厄洛替尼雜質(zhì)45 |
183321-83-7 |
詳細(xì)
|
| Erlotinib Impurity 71 |
厄洛替尼雜質(zhì)9 |
2055840-54-3 |
詳細(xì)
|
| Erlotinib Impurity 46 |
厄洛替尼雜質(zhì)46 |
938185-06-9 |
詳細(xì)
|
| Febuxostat Impurity 41;4-hydroxybenzothioamide |
非布索坦雜質(zhì)41 |
|
詳細(xì)
|
| Febuxostat Impurity 50;ethyl 2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)50 |
144060-84-4 |
詳細(xì)
|
| Esomeprazole Impurity 25;2-(((3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-6-methoxy-1H-benzo[d]imidazole |
埃索美拉唑雜質(zhì)25 |
1080689-87-7 |
詳細(xì)
|
| Erlotinib iMpurity 40 |
厄洛替尼雜質(zhì)40 |
|
詳細(xì)
|
| GLUTATHIONESULFONIC ACID |
磺酸谷胱甘肽 |
3773-07-7 |
詳細(xì)
|
| Erlotinib Impurity 11 |
厄洛替尼代謝產(chǎn)物M11 |
882172-60-3 |
詳細(xì)
|
| Hydroxy Darunavir |
達(dá)魯那韋雜質(zhì)5 |
1130635-75-4 |
詳細(xì)
|
| Erlotinib Impurity 66 |
厄洛替尼雜質(zhì)66 |
1384975-87-4 |
詳細(xì)
|
| Ivabridine impurity 50 |
伊伐布雷定雜質(zhì)4 |
85175-52-6 |
詳細(xì)
|
| Ezetimibe Impurity Q1;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((S)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one |
依折麥布雜質(zhì)Q1 |
|
詳細(xì)
|
| Fimasartan Impurity I |
非馬沙坦雜質(zhì)I |
|
詳細(xì)
|
| Febuxostat Impurity 30;(Z)-ethyl 2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)30 |
|
詳細(xì)
|
| Febuxostat Impurity 37 |
非布索坦雜質(zhì)46 |
2230270-05-8 |
詳細(xì)
|
| Erlotinib Impurity 39 |
厄洛替尼雜質(zhì)39 |
|
詳細(xì)
|
| Erlotinib Impurity 29 |
厄洛替尼雜質(zhì)29 |
574738-66-2 |
詳細(xì)
|
| Linagliptin Impurity 3 |
利格列汀雜質(zhì)3 |
|
詳細(xì)
|
| Febuxostat Impurity 30 |
非布司他雜質(zhì)6 |
1271738-74-9 |
詳細(xì)
|
| Ivabradine Impurity 6 |
伊伐布雷定雜質(zhì)6 |
148849-68-7 |
詳細(xì)
|
| Gefitinib iMpurity E |
吉非替尼雜質(zhì)E |
|
詳細(xì)
|
| Levetiracetam Impurity G;ethyl (S)-2-(2-oxopyrrolidin-1-yl)butanoate |
左乙拉西坦雜質(zhì)G |
1862335-58-7 |
詳細(xì)
|
| Febuxostat Impurity 44;ethyl 2-(3-formyl-2-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)44 |
|
詳細(xì)
|
| Febuxostat Impurity 52 |
非布索坦雜質(zhì)52 |
|
詳細(xì)
|
| Febuxostat related Compound 4;2-hydroxybenzothioamide |
非布索坦起始物料4 |
|
詳細(xì)
|
| Ivabradine related compound 3;7,8-dimethoxy-3-propyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one |
伊伐布雷定相關(guān)化合物3 |
|
詳細(xì)
|
| Febuxostat Impurity 52 |
非布司他雜質(zhì)52 |
18962-07-7 |
詳細(xì)
|
| Fluconazole Impurity J;2-(2-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol |
氟康唑雜質(zhì)J |
|
詳細(xì)
|
| Febuxostat Impurity 53;isobutyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)53 |
1346238-13-8 |
詳細(xì)
|
| Febuxostat Impurity 32;2-(4-hydroxy-3-((hydroxyimino)methyl)phenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)32 |
1805770-41-5 |
詳細(xì)
|
| Febuxostat Impurity 43;4-hydroxyisophthalonitrile |
非布索坦雜質(zhì)43 |
|
詳細(xì)
|
| Febuxostat Impurity 47;2-(2-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)47 |
|
詳細(xì)
|
| Erlotinib impurity 70 |
厄洛替尼雜質(zhì)67 |
1494468-76-6 |
詳細(xì)
|
| Gefitinib iMpurity N |
吉非替尼雜質(zhì)N |
|
詳細(xì)
|
| Erlotinib O-Desmethyl Metabolite Isomer (M13) |
厄洛替尼雜質(zhì) |
183320-29-8 |
詳細(xì)
|
| Ezetimibe Impurity Q2;(S)-3-((2R,5R)-5-(4-fluorophenyl)-5-hydroxy-2-((R)-hydroxy(4-hydroxyphenyl)methyl)pentanoyl)-4-phenyloxazolidin-2-one |
依折麥布雜質(zhì)Q2 |
|
詳細(xì)
|
| Febuxostat Impurity 31;diethyl 2,2'-(4-hydroxy-5-(hydroxymethyl)-1,3-phenylene)bis(4-methylthiazole-5-carboxylate) |
非布索坦雜質(zhì)31 |
|
詳細(xì)
|
| Febuxostat Impurity 82 |
非布索坦雜質(zhì)45 |
2230270-03-6 |
詳細(xì)
|
| (R)-Amlodipine |
非布司他雜質(zhì)25 |
2095166-41-7 |
詳細(xì)
|
| Ivabradine Impurity 13 |
伊伐布雷定雜質(zhì)13 |
|
詳細(xì)
|
| Febuxostat Impurity 88 |
非布索坦雜質(zhì)57 |
886501-78-6 |
詳細(xì)
|
| Folic Acid-13C5 |
葉酸-13C5 |
1207282-75-4 |
詳細(xì)
|
| Erlotinib Impurity 67 |
厄洛替尼雜質(zhì)44 |
183321-85-9 |
詳細(xì)
|
| Ivabradine Impurity 15 |
伊伐布雷定雜質(zhì)10 |
1616710-50-9 |
詳細(xì)
|
| Ivabradine related compound 12 |
伊伐布雷定雜質(zhì)3 |
1132667-04-9 |
詳細(xì)
|
| Febuxostat Impurity 36;2-(3-cyano-4-ethoxyphenyl)-4-methylthiazole-5-carboxylic acid |
非布索坦雜質(zhì)36 |
1805770-40-4 |
詳細(xì)
|
| Gefitinib iMpurity J |
吉非替尼雜質(zhì)J |
|
詳細(xì)
|
| Hydroxybupropion |
安非他酮雜質(zhì) |
92264-81-8 |
詳細(xì)
|
| Rosuvastatin EP Impurity A |
葉酸雜質(zhì)6 |
948-60-7 |
詳細(xì)
|
| Gefitinib iMpurity M |
吉非替尼雜質(zhì)M |
|
詳細(xì)
|
| Linagliptin Impurity |
利格列汀雜質(zhì)CD10088對(duì)照品 |
|
詳細(xì)
|
| 3, 4-dihydroxybenzaldehyde |
厄洛替尼雜質(zhì)68 |
139-85-5 |
詳細(xì)
|
| Vitamin B6 Impurity 60 |
葉酸雜質(zhì)5 |
712-30-1 |
詳細(xì)
|
| Fudosteine Impurity 6 |
福多司坦雜質(zhì)7 |
30453-21-5 |
詳細(xì)
|
| Roxastat |
羅沙司他雜質(zhì)ABCDEFGHJKL |
808118-40-3 |
詳細(xì)
|
| Folic Acid EP Impurity D |
葉酸EP雜質(zhì)D |
119-24-4 |
詳細(xì)
|
| Febuxostat Impurity 47 |
非布司他雜質(zhì)47 |
161718-85-0 |
詳細(xì)
|
| Linagliptin Impurity X |
利格列汀雜質(zhì)IH |
1646355-34-1 |
詳細(xì)
|
| Febuxostat Impurity 46 |
非布司他雜質(zhì)19 |
118485-48-6 |
詳細(xì)
|
| Febuxostat iMpurity 20 |
非布索坦雜質(zhì)20 |
|
詳細(xì)
|
| Gadobutrol Impurity 14 |
釓布醇雜質(zhì)14 |
220182-11-6 |
詳細(xì)
|
| Valsartan Methyl Ester |
夫西地酸 |
6990-06-3 |
詳細(xì)
|
| Febuxostat Impurity 106 |
非布索坦雜質(zhì)54 |
1346238-15-0 |
詳細(xì)
|
| Febuxostat Impurity 49;ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate |
非布索坦雜質(zhì)49 |
|
詳細(xì)
|
| Ivabradine related compound 10;(R)-N-((3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methylacetamide |
伊伐布雷定相關(guān)化合物10 |
|
詳細(xì)
|
| Levetiracetam Impurity F;methyl (S)-2-(2-oxopyrrolidin-1-yl)butanoate |
左乙拉西坦雜質(zhì)F |
7324-11-0 |
詳細(xì)
|
| Ivabradine Impurity 14;3-(3-((((R)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)(methyl)amino)propyl)-1-hydroxy-7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one |
伊伐布雷定雜質(zhì)14 |
|
詳細(xì)
|
| Ezetimibe Impurity R |
依折麥布雜質(zhì)R |
|
詳細(xì)
|
| Febuxostat Impurity 40;4-hydroxybenzonitrile |
非布索坦雜質(zhì)40 |
|
詳細(xì)
|
| Fudosteine Impurity 2 |
福多司坦雜質(zhì)2 |
1480319-53-6 |
詳細(xì)
|
| Gadobutrol Impurity 8 |
釓布醇雜質(zhì)8 |
60239-18-1 |
詳細(xì)
|
| Isolopinavir |
洛匹那韋氨基醇雜質(zhì) |
1132765-59-3 |
詳細(xì)
|